Clinical Trials
15
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Combined AlloStim+Anti-PD-L1 in MSS Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06557278
- Locations
- 🇺🇸
New York Cancer and Blood Specialists, Shirley, New York, United States
🇺🇸Mt. Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
🇺🇸Hirschfield Oncology Center, Brooklyn, New York, United States
Immunotherapy for Advanced Liver Cancer
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2021-09-02
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05033522
- Locations
- 🇲🇾
Sultan Ismail Hospital, Johor Bahru, Johor, Malaysia
🇲🇾Sultanah Bahiyah Hospital, Alor Setar, Kedah, Malaysia
🇲🇾Columbia Asia Bukit Rimau, Shah Alam, Selangor Darul Ehsan, Malaysia
Immunotherapy for Third Line Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2020-06-23
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT04444622
- Locations
- 🇺🇸
Mt. Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸Summit Health, Florham Park, New Jersey, United States
Universal Anti-Viral Vaccine for Healthy Elderly Adults
- Conditions
- PneumoniaCOVID-19 Respiratory InfectionRSV PneumoniaVirus DiseasesInfluenza, HumanARDS, Human
- Interventions
- First Posted Date
- 2020-06-22
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Mirror Biologics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04441047
- Locations
- 🇺🇸
Delray Physician Care Center, Delray Beach, Florida, United States
🇺🇸Coral Research Clinic & Coral Diagnostic, Miami, Florida, United States
🇺🇸Model Research, Tampa, Florida, United States
Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
- Conditions
- Squamous Cell Carcinoma Head and Neck
- Interventions
- Biological: AlloVax™
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Mirror Biologics, Inc.
- Registration Number
- NCT02624999
- Locations
- 🇹🇭
National Cancer Institute of Thailand, Bangkok, Thailand
- Prev
- 1
- 2
- 3
- Next